Robert A. Leadbetter, MD
- 2Articles
- 20.8KReads1
- 2002–2021Active
- 17Collaborators
- 9Citations2
About
Robert A. Leadbetter, MD, is affiliated with Global Research & Development at Indivior Inc. in North Chesterfield, Virginia. His publications, spanning from 2002 to 2021, focus on schizophrenia and schizoaffective disorders as well as sexual dysfunction. His work includes analyses of extended-release risperidone in schizophrenia patients and investigations into the prevalence of sexual dysfunction associated with newer antidepressants.
Publications
Response to Subcutaneous Injectable Monthly Risperidone (RBP-7000): PANSS Item-Level Analysis
September 21, 2021
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
